Nobel Prize-winning research identified genes (Yamanaka factors) that revert specialized adult cells back into their embryonic, stem-cell state. This discovery proves cellular differentiation and aging are not irreversible, opening the door for regenerative therapies by "rebooting" cells to an earlier state.

Research in mice challenges the idea that females simply run out of eggs. By treating old female mice, scientists rejuvenated their ovaries, enabling them to produce healthy offspring again, suggesting age-related infertility could be treatable.

Some individuals possess genetic variants, like FOXO3, that slow their biological clocks. The goal of emerging "gero-protectors" is not immortality but to replicate this advantage for everyone, slowing aging to compress frailty into a shorter period at the end of life and extend healthspan.

Dr. Aubrey de Grey posits that a "preventative maintenance" approach—repairing accumulated cellular damage—is a more direct and achievable engineering problem than trying to slow the complex metabolic processes that cause the damage in the first place, sidestepping our biological ignorance.

A medical procedure called therapeutic plasma exchange, where a person's plasma is removed and replaced with albumin, shows anti-aging potential. In small placebo-controlled trials, this process led to epigenetic markers indicating that some organs and the body overall looked biologically younger.

The physical decline, decreased mobility, and frailty common in the elderly, even without a specific diagnosed disease, can be directly attributed to the accumulation of senescent cells. This links a macro-level health observation to a specific cellular process, identifying a tangible target for therapeutic intervention against age-related weakness.

Aging is not wear and tear, but a loss of epigenetic information. Cells lose their identity, akin to corrupted software. The body holds a "backup copy" of youthful information that can be reinstalled, fundamentally making age reversal possible.

In a process called parabiosis, surgically joining a young and old mouse to share circulation revealed that factors in young blood can reverse key aging markers in the brain. This led to reactivated stem cells, reduced inflammation, and improved memory in the older mice.

It is now possible to combine the nuclear DNA from a mother and father with the mitochondrial DNA from a third-party egg donor. This "three-parent IVF," approved in the UK for mitochondrial diseases, creates a child with the genetic makeup of two parents and the mitochondrial health of a third.